Home
>
National Drug Code (NDC)
>
SUTENT
SUTENT - 0069-0770-38 - (SUNITINIB MALATE)
Drug Information of SUTENT
| Product NDC: | 0069-0770 |
| Proprietary Name: | SUTENT |
| Non Proprietary Name: | SUNITINIB MALATE |
| Active Ingredient(s): | 25 mg/1 & nbsp; SUNITINIB MALATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SUTENT
| Product NDC: | 0069-0770 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021938 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060126 |
Package Information of SUTENT
| Package NDC: | 0069-0770-38 |
| Package Description: | 28 CAPSULE in 1 BOTTLE (0069-0770-38) |
NDC Information of SUTENT
| NDC Code | 0069-0770-38 |
| Proprietary Name | SUTENT |
| Package Description | 28 CAPSULE in 1 BOTTLE (0069-0770-38) |
| Product NDC | 0069-0770 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SUNITINIB MALATE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20060126 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | SUNITINIB MALATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
